| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |